Actinium Pharmaceuticals, Inc. (ATNM)
1.05
-0.02
(-1.87%)
USD |
NYAM |
Nov 20, 16:00
1.06
+0.01
(+0.95%)
After-Hours: 20:00
Actinium Pharmaceuticals Debt to Equity Ratio : 0.0471 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0471 |
| June 30, 2026 | 0.0443 |
| March 31, 2026 | 0.6593 |
| December 31, 2025 | 0.2162 |
| September 30, 2025 | 0.0829 |
| June 30, 2025 | 0.0678 |
| March 31, 2025 | 0.0558 |
| December 31, 2024 | 0.048 |
| September 30, 2024 | 0.0448 |
| June 30, 2024 | 0.0422 |
| March 31, 2024 | 0.0452 |
| December 31, 2023 | 0.0581 |
| September 30, 2023 | 0.0507 |
| June 30, 2023 | 0.044 |
| March 31, 2023 | 0.043 |
| December 31, 2022 | 0.0388 |
| September 30, 2022 | 0.0365 |
| June 30, 2022 | 0.0339 |
| March 31, 2022 | 0.0029 |
| December 31, 2021 | 0.0042 |
| September 30, 2021 | 0.0052 |
| June 30, 2021 | 0.0066 |
| March 31, 2021 | 0.009 |
| December 31, 2020 | 0.012 |
| September 30, 2020 | 0.0193 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0215 |
| March 31, 2020 | 0.4315 |
| December 31, 2019 | 0.253 |
| September 30, 2019 | 0.1259 |
| June 30, 2019 | 0.0903 |
| March 31, 2019 | 0.2947 |
| December 31, 2018 | 0.0298 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0047 |
| March 31, 2016 | 0.0089 |
| December 31, 2015 | 0.0121 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.004 |
| March 31, 2015 | 0.0115 |
| December 31, 2014 | -0.1475 |
| September 30, 2014 | 3.464 |
| June 30, 2014 | 2.282 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0518 |
| Alnylam Pharmaceuticals, Inc. | 0.8316 |
| Anika Therapeutics, Inc. | 0.1901 |
| Savara, Inc. | 0.2815 |
| Arrowhead Pharmaceuticals, Inc. | 27.84 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 32.46M |
| Total Liabilities (Quarterly) | 7.88M |
| Shareholders Equity (Quarterly) | 24.58M |
| Current Ratio | 4.002 |
| Net Debt Paydown Yield | 0.08% |